RespireRx Pharmaceuticals Inc (RSPI)

[davidal66]

GFP, right, but Cortex also looked at additional tissue samples of the primate collection where something of question was found, no additional atypical samples. In the last five months, Cortex also did the acute ultra-high dose CX717 dosing to a group of primates and this was clean. So last Summer, the began another CX717 three month test(on advice from--and input by)their consultants again in primates at a higher dose.